Waldenström's Macroglobulinaemia

Overview and management of IgM-associated lymphoma.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyOncology

Clinical Guidelines

ESMO Clinical Practice Guidelines: Waldenström's Macroglobulinaemia
National
Guidelines on the diagnosis and management of Waldenström macroglobulinaemia
National
NICE Technology Appraisal Guidance [TA795]: Ibrutinib for treating Waldenstrom's macroglobulinaemia
National
NICE Technology Appraisal Guidance [TA833]: Zanubrutinib for treating Waldenstrom's macroglobulinaemia
National
ESMO Clinical Practice Guidelines: Waldenström's macroglobulinaemia – diagnosis, treatment and follow-up
Local
NCCN Clinical Practice Guidelines in Oncology: Waldenström's Macroglobulinaemia/Lymphoplasmacytic Lymphoma (Version 2.2020)
Local